The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Compounds · Repair & healing peptides · continued

Reading a preclinical wound-healing model and its relevance to a human tendon posts 151–161

This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1.

WP
weekly_pinTL2Regular26 Nov 2024#151

Picking up post #149: that is the part I would want checked first.

Taking reading a preclinical wound-healing model seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled comparison, and those two things support very different sentences.

8 likes 20mo
AD
a.delgadoTL226 Nov 2024#152

Reading a preclinical wound-healing model: the model shows whether a mechanism is plausible in a specific context. It does not show magnitude of effect in humans, does not show safety profile in humans, and does not show whether the effect survives in a more complex biological system. That is not a criticism of preclinical work — it is what preclinical work is for.

A single observation, in a thread that deserves better than single observations.

20 likes 20mo
MH
m.haddadTL2Regular26 Nov 2024#153

Following this. I have the same question and no better information than the first post.

0 likes 20mo
KM
k.marchandTL226 Nov 2024#154
taper_table, post #83: The version of reading a preclinical wound-healing model that I was taught turned out to be a teaching simplification. Useful, and not true in the way I had assumed it was. Go to post

Reported local reactions are common enough in first-hand accounts here to be worth mentioning and are not characterised in any published series.

2 likes in reply to #83 20mo
TH
TL4_HalvorsenTL4Leader · Journal club26 Nov 2024#155

For anyone arriving from search engines: this subcategory discusses published preclinical work and the absence of published clinical work. It does not endorse or recommend these compounds.

The answer changed when I changed how I was measuring, which was informative.

13 likes 20mo
HL
h.lindqvistTL226 Nov 2024 · edited#156

Reading back through the reading a preclinical wound-healing model threads from last year, the same three questions come up every time and only one of them has ever been answered properly. That seems like a documentation gap rather than a knowledge gap.

27 likes 20mo
AD
appeals_deskTL3Regular26 Nov 2024#157
ro.frisk, post #34: Research use only, not approved for human use, and in this family that statement carries more weight than usual because the published human safety data is effectively absent rather than merely limited. I would treat that as a working assumption and revisit it. Go to post

The lyophilised cake is worth looking at before adding diluent. A collapsed or shrunken cake is not a purity finding but it does say something about how the vial was made and how it travelled.

0 likes in reply to #34 20mo
SA
s.adebayoTL226 Nov 2024#158
s.achebe, post #69: Adding the measurement that post #67 says would settle it. Marking my uncertainty on reading a preclinical wound-healing model explicitly. I am confident about the direction, much less confident about the size, and not confident at all that it generalises past the case in the first post. Go to post

Where I part company with post #156, and it is a narrow parting.

BPC-157's published evidence is overwhelmingly preclinical and mostly rodent. That is not a dismissal — it is the state of the literature, and any discussion that starts elsewhere is starting from something that is not there.

The mechanism is plausible, which is not the same as established.

4 likes in reply to #69 20mo
C
chromatogramTL4Analytical chemist27 Nov 2024#159
e.mensa, post #88: What would change the position on repair peptides: adequately powered, published, peer-reviewed randomised controlled human trials with pre-specified outcomes. That is the standard applied to every other therapeutic claim on this site and it is the standard applied here. The claim is narrower than it sounds, and deliberately so. Go to post

Genuine question rather than a rhetorical one: has anyone here actually observed reading a preclinical wound-healing model, as opposed to read about it? The thread is long and I cannot tell.

2 likes in reply to #88 20mo
TD
t.dumitruTL227 Nov 2024#160

Nothing in this subcategory is medical advice and several members here are describing experiments on themselves. Both of those things should be stated plainly rather than implied.

9 likes 20mo
II
i.ilungaTL227 Nov 2024#161

Post #157 put the caveat in the right place and I want to underline it.

I have three months of notes on reading a preclinical wound-healing model and the honest summary is that the trend is real and the week-to-week numbers are noise. I nearly drew the opposite conclusion from the first fortnight.

22 likes 20mo
This topic was closed 30 days after the last reply. Closing is automatic for quiet topics so that a settled answer does not collect new questions underneath it. If you have a follow-up, open a new topic and link back to this one — that keeps both readable and gives your question its own title.

Suggested topics

TopicParticipantsRepliesViewsActivity
Stability of BPC-157 in solution: what has been measured — one year on
On the subject in the title: Stability of BPC-157 in solution: what has been measured — one year on Working notes rather than a conclusion. A narrow question about Stability of BPC-157, deliberately narrow,…
KFNASCPWVB+84 98 7.8k 18h
What would change my mind about repair peptides: a specific answer — one year on
What would change my mind about repair peptides: a specific answer — one year on I have a specific reason for asking rather than idle curiosity, and the context is below. Documentation question rather than a…
CTLLFVON+9 13 42k 19mo
About the Repair & healing peptides category
BPC-157, TB-500 and similar. Mostly preclinical evidence; this subcategory is strict about not overstating it. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit…
SLHSENALEF 4 19k 13mo
BPC-157: what the rodent literature actually shows, and what it does not — a second dataset
On the subject in the title: BPC-157: what the rodent literature actually shows, and what it does not — a second dataset Working notes rather than a conclusion. The question about BPC-157 that I actually want…
WNCDSOOSB+77 84 54k 11mo
Revisiting: Oral versus injected administration claims for BPC-157
On the subject in the title: Revisiting: Oral versus injected administration claims for BPC-157 Working notes rather than a conclusion. A follow-up question about Oral versus injected administration claims…
IGAAILRILD+23 27 7.7k 15mo

Related topics — sharing the tags TB-500, preprint, observational data

TopicParticipantsRepliesViewsActivity
Aggregated purity results across four services, with caveats — a second dataset
Aggregated purity results across four services, with caveats — a second dataset — setting out what I have, and where I think it stops being reliable. Posting a small dataset on Aggregated purity results…
CWFNHLTHRE+127 151 42k 10mo
Coming back to: Why a preprint's supplementary material is often the best part
Why a preprint's supplementary material is often the best part — that is the question, and I have not found it answered plainly anywhere I have looked. A question about how this site should cite something…
GDIBDTHFBV+109 116 36k 2d
Citing a preprint in a maintained document: our rule and its reasoning — does this still hold?
The question in the title: Citing a preprint in a maintained document: our rule and its reasoning — does this still hold? I will give what I have already checked below so nobody repeats it. A question about…
CRFDSIAST+103 115 24k 10mo
Immortal time bias in a claims-database study
Immortal time bias in a claims-database study — setting out what I have, and where I think it stops being reliable. Asking about immortal time bias directly, because I have read four threads on it and each…
MACDSOIDNN+29 34 28k 11mo
Coming back to: A community side-effect dataset, with its response rate and biases
On the subject in the title: A community side-effect dataset, with its response rate and biases Working notes rather than a conclusion. Reading back through what has been written here about community…
AATSCNPMA+27 31 46k 9mo